
Age-related macular degeneration can lead to vision loss in seniors, but new therapies have offered fresh hope for preserving eyesight later in life, eye experts say. These cutting-edge therapies benefit both the dry and wet types of age-related macular degeneration (AMD), says the American Society of Retina Specialists (ASRS). Eleven million people in the United States have AMD, with dry AMD affecting about 85% and wet AMD striking 15%. “Patients often tell me they are sure they will lose their vision because they have a family member who experienced vision loss from AMD, but with early diagnosis and treatment, we now have much more than hope to offer patients with wet or dry AMD,” ASRS Foundation President Dr. Judy Kim said in a news release. The macula is a round area at the center of the retina, which is the layer of light-sensitive cells at the back of the eyeball that capture images. People with AMD slowly begin to lose their central vision, according to the American Academy of Ophthalmology. They can’t see fine details either up close or far away, but their peripheral vision remains normal. The AAO gives the example of looking at a clock with hands. People with AMD might see the clock’s numbers, but not the hands. Most patients have early or intermediate dry AMD, which can remain stable for a… read on > read on >